Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Xiidra® (lifitegrast ophthalmic solution) 5% logo — For US Audiences only. Learn more at https://www.xiidra-ecp....

Xiidra® (lifitegrast ophthalmic solution) 5%

For US Audiences only. Learn more at https://www.xiidra-ecp.com.

Founded 2016 0-1 employees Biopharma, Health Care

General Information

Company Name Xiidra® (lifitegrast ophthalmic solution) 5%
Founded Year 2016
Employees 0-1
Industries Biopharma, Health Care
Social

Get notified when Xiidra® (lifitegrast ophthalmic solution) 5% moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Xiidra® (lifitegrast ophthalmic solution) 5%

Xiidra, a biopharma startup founded in 2016, aims to alleviate the signs and symptoms of dry eye disease with its prescription eye drop solution. The company's slogan, "Xiidra helps treat dry eye disease, proven to reduce symptoms and staining score in clinical studies." reflects its focus on providing effective treatment. Xiidra's effectiveness has been validated through four distinct 12-week clinical studies involving over 1,000 patients. Results from these studies have demonstrated that Xiidra effectively reduces eye dryness symptoms across all four trials. Additionally, the solution has shown improvement in the Inferior Fluorescein Corneal Staining Score in three of the four studies for some patients at the 12-week mark. With a primary focus on the Biopharma and Health Care industries, Xiidra presents a promising opportunity for investors and has the potential to make a significant impact in the field of ophthalmology.

Taxonomy: ophthalmology, dry eye disease, prescription medication, clinical studies, eye health, eye drop solution, medical treatment, pharmaceuticals

No funding data available for Xiidra® (lifitegrast ophthalmic solution) 5% yet.

Get notified when Xiidra® (lifitegrast ophthalmic solution) 5% raises funding

Xiidra® (lifitegrast ophthalmic solution) 5% Alternatives & Competitors

Xiidra® (lifitegrast ophthalmic solution) 5% vs
Bausch + Lomb UK
Bausch + Lomb UK United Kingdom

See Better. Live Better #togetherwithbausch #joinbausch #seebetterlivebetter

78 employees
Fashion, Manufacturing
Xiidra® (lifitegrast ophthalmic solution) 5% vs
Bausch Health Companies Inc.
Bausch Health Companies Inc. Canada

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global, diversified health care company that devel...

Post Ipo Debt
2720 employees
Biotechnology, Health Care
Xiidra® (lifitegrast ophthalmic solution) 5% vs
OCC Eyecare
OCC Eyecare Canada

OCC Eyecare is the largest independent centre for Ophthalmology in Canada. Our multidisciplinary f...

48 employees

FAQ About Xiidra® (lifitegrast ophthalmic solution) 5%

For US Audiences only. Learn more at https://www.xiidra-ecp.com.
Xiidra® (lifitegrast ophthalmic solution) 5% was founded in 2016.
Xiidra® (lifitegrast ophthalmic solution) 5% operates in the following industries: Biopharma, Health Care.
Xiidra® (lifitegrast ophthalmic solution) 5% has approximately 0-1 employees.
Top alternatives and competitors to Xiidra® (lifitegrast ophthalmic solution) 5% include Bausch + Lomb UK, Bausch Health Companies Inc., OCC Eyecare, LumenData, Luminopia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xiidra® (lifitegrast ophthalmic solution) 5% and Bausch + Lomb UK are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Xiidra® (lifitegrast ophthalmic solution) 5% and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy